Revenue
2022
2023
2024
2025
MANGOCEUTICALS, INC. (MGRX)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $456,021 | $615,873 | $731,493 | $8,939 |
| Gross profit | $250,386 | $379,964 | $431,501 | $4,850 |
| Operating expenses | $18.3M | $8.4M | $9.7M | $2.0M |
| Operating income | −$18.0M | −$8.0M | −$9.2M | −$2.0M |
| EBITDAderived | −$16.9M | −$8.0M | −$9.2M | — |
| Net income | −$20.6M | −$8.7M | −$9.2M | −$2.0M |
| Basic EPSper diluted share | -$2.17 | -$4.80 | -$8.58 | -$0.19 |
| Diluted EPSper diluted share | -$2.17 | -$4.80 | -$8.58 | -$0.19 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 15, 2025Form 4 | JOHNSTON EUGENE MCFO | SellCommon Stock | 3.3K | $1.17 | $3.9K | 120.0K |
| Dec 9, 2025Form 4 | JOHNSTON EUGENE MCFO | SellCommon Stock | 5.0K | $1.20 | $6.0K | 123.3K |
| Dec 5, 2025Form 4 | JOHNSTON EUGENE MCFO | SellCommon Stock | 10.0K | $1.13 | $11.3K | 128.3K |
| Nov 19, 2025Form 4 | Hamilton Alex P.Director | SellCommon Stock | 125.0K | $1.22 | $152.5K | 3.3K |